#United States #New York #Novo Nordisk #Wegovy #Ro

Ro Launches New Patient Offer for Wegovy

Ro, a leading telehealth platform, has made headlines by introducing an attractive offer for new patients interested in obesity management. As of May 22, 2025, Ro will provide the first month of Novo Nordisk's Wegovy® for a reduced cash price of $199, targeting those embarking on their journey towards better health.

Accessibility to Quality Obesity Care

This initiative is not just about pricing; it's a significant step towards enhancing accessibility to FDA-approved GLP-1 medications. By partnering with Novo Nordisk through their NovoCare® Pharmacy, Ro aims to offer a seamless experience, enabling new patients to benefit from high-quality, proven treatments right at their fingertips.

Membership Benefits

In addition to the Wegovy offer, Ro is also promoting its Body membership plan, which is available at a discounted rate of $45 for the first month. This membership encompasses a multitude of services crucial for effective weight management, including:

• - Access to licensed healthcare providers
• - 24/7 messaging support
• - Personalized 1-on-1 coaching
• - Educational resources on health and nutrition
• - Weight tracking and dosage monitoring
• - Regular check-ins for side-effect management and dosage adjustments

Patients can access comprehensive obesity care that includes both the Wegovy treatment and continuous support for a total of $244 in the first month, all managed conveniently through the Ro app.

Leadership Insights

Dave Moore, Executive Vice President of U.S. Operations for Novo Nordisk, shared his enthusiasm about the partnership, stating, "Through our collaboration with Ro, we are able to further expand access to authentic, FDA-approved Wegovy®. This promotion effectively reduces barriers, making obesity care more accessible to those who need it."

Zach Reitano, co-founder and CEO of Ro, echoed these sentiments, emphasizing the company's commitment to affordability and convenience. He noted, "By leveraging technology, we are significantly lowering the costs associated with high-quality healthcare. Our platform makes it easy to navigate insurance options and find the best treatment solutions."

Comprehensive GLP-1 Options

Ro's obesity care formulary is noted as one of the most extensive available among telehealth services, incorporating both branded cash pay options as well as those eligible for insurance reimbursement. Patients can choose between picking up their medication at a local pharmacy or opting for delivery to their home. Additionally, Ro features a GLP-1 insurance checker, allowing users to verify their insurance benefits without any cost, ensuring they find the most economical medication options.

To date, Ro has successfully assisted hundreds of thousands of individuals in understanding their insurance coverage and obtaining the most suitable treatments. They are committed to providing a comprehensive suite of GLP-1 medication options, allowing patients to tailor their approach to weight loss effectively.

About Ro

Ro's mission centers on empowering patients to achieve their health goals through accessible, efficient healthcare solutions. As a direct-to-patient company, Ro offers nationwide telehealth services, lab testing, and pharmacy services, all integrated into one platform. Since its launch in 2017, Ro has reached millions across the United States, including underserved areas and primary care deserts.

For more detailed information on Ro’s Body membership and the full range of GLP-1 options, prospective patients can visit the official website at Ro.co/weightloss. It’s a pivotal moment in healthcare, emphasizing the importance of making effective obesity management solutions both affordable and easily accessible for all.

Important Safety Information

For important safety details about GLP-1 medications, including boxed warnings, readers are encouraged to check the safety information available at Ro's website.